First case report of topical tacalcitol for vitiligo repigmentation

Pediatric Dermatology

Volumn 25, Issue 2, 2008, Pages 262-264

  Amano, Hiroo ^a   Abe, Masatoshi ^a   Ishikawa, Osamu ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; TACALCITOL;

ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; DRUG TREATMENT FAILURE; FEMALE; HUMAN; LEUKODERMA; PHOTOTHERAPY; PRIORITY JOURNAL; SCHOOL CHILD; SYMPTOM; VITILIGO;

ADMINISTRATION, CUTANEOUS; CHILD; DERMATOLOGIC AGENTS; DIHYDROXYCHOLECALCIFEROLS; FEMALE; HUMANS; OINTMENTS; SUNLIGHT; VITILIGO;

EID: 42549131886     PISSN: 07368046     EISSN: 15251470     Source Type: Journal    
DOI: 10.1111/j.1525-1470.2008.00648.x     Document Type: Article

References (8)

1. Kovacs SO. Vitiligo. J Am Acad Dermatol 1998 38 : 667 668.
2. Parsad D, Saini R, Nagapal R. Calcipotriol in vitiligo: a preliminary study. Pediatr Dermatol 1999 16 : 317 320.
3. Parsad D, Saini R, Verma N. Combination of PUVAsol and topical calcipotriol in vitiligo. Dermatology 1998 197 : 167 170.
4. Travis LB, Silverberg NB. Calcipotriene and corticosteroid combination therapy for vitiligo. Pediatr Dermatol 2004 21 : 495 498.
5. Kumaran MS, Kaur I, Kumar B. Effect of topical calcipotriol, betamethasone dipropionate and their combination in the treatment of localized vitiligo. J Eur Acad Dermatol Venereol 2006 20 : 269 273.
6. Tomita Y, Miyamura Y, Kono M et al. Molecular bases of congenital hypopigmentary disorders in humans and oculocutaneous albinism 1 in Japan. Pigment Cell Res 2000 13 (Suppl. 8 130 134.
7. Milde P, Hauser U, Simon T et al. Expression of 1,25-dihydroxyvitamin D3 receptors in normal and psoriatic skin. J Invest Dermatol 1991 97 : 230 239.
8. Katayama I, Ashida M, Maeda A et al. Open trial of topical tacalcitol [1 alpha 24(OH)2D3] and solar irradiation for vitiligo vulgaris: upregulation of c-Kit mRNA by cultured melanocytes. Eur J Dermatol 2003 13 : 372 376.